---
title: "Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288183915.md"
description: "On May 21, 2026, Immix Biopharma, Inc. revealed the pricing details of its underwritten registered offering, consisting of 16,778,524 shares of common stock priced at $8.94 per share for a total public price of $150 million, excluding underwriting discounts and expenses. The offering is set to conclude around May 22, 2026, pending the fulfillment of standard closing conditions."
datetime: "2026-05-31T21:44:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288183915.md)
  - [en](https://longbridge.com/en/news/288183915.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288183915.md)
generator: "portal-rs"
---

# Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock

On May 21, 2026, Immix Biopharma, Inc. revealed the pricing details of its underwritten registered offering, consisting of 16,778,524 shares of common stock priced at $8.94 per share for a total public price of $150 million, excluding underwriting discounts and expenses. The offering is set to conclude around May 22, 2026, pending the fulfillment of standard closing conditions.

### Related Stocks

- [IMMX.US](https://longbridge.com/en/quote/IMMX.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)

## Related News & Research

- [Immix Biopharma highlights NXC-201 CAR-T data in relapsed/refractory AL amyloidosis trial presentation](https://longbridge.com/en/news/297810101.md)
- [09:28 ETNew LabCentral Program "The Loop" Offers International Biotech Start-Ups and Partner Organizations Curated Learnings Directly from U.S. Market](https://longbridge.com/en/news/298328140.md)
- [FDA grants priority review to Genentech’s Enspryng for MOGAD](https://longbridge.com/en/news/298539804.md)
- [Velan Capital Investment Management LP Has $11.19 Million Stock Holdings in Immix Biopharma, Inc. $IMMX](https://longbridge.com/en/news/297768757.md)
- [Immix Biopharma publishes corporate presentation on NXC-201 BCMA CAR-T in relapsed/refractory AL amyloidosis](https://longbridge.com/en/news/295441199.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**